The management of tuberculous pericardial effusion: Experience in 233 consecutive patients

Cardiovascular Journal of South Africa

Volumn 18, Issue 1, 2007, Pages 20-25

  Reuter, Helmuth ^a   Burgess, Lesley J ^a   Louw, Vernon J ^a   Doubell, Anton F ^a  

^a STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID DERIVATIVE; COTRIMOXAZOLE; TUBERCULOSTATIC AGENT; CORTICOSTEROID;

ADJUVANT THERAPY; ADULT; ARTICLE; CLINICAL EVALUATION; CONSTRICTIVE PERICARDITIS; CONTROLLED STUDY; CORTICOSTEROID THERAPY; ECHOCARDIOGRAPHY; FEMALE; HEART CATHETERIZATION; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN TISSUE; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL EXAMINATION; MORTALITY; PATIENT CARE; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PERICARDITIS; POSTOPERATIVE COMPLICATION; SHORT COURSE THERAPY; SURGICAL DRAINAGE; TREATMENT OUTCOME; HISTOLOGY; HUMAN IMMUNODEFICIENCY VIRUS; INDWELLING CATHETER; INFORMED CONSENT; MICROBIOLOGY; RADIODIAGNOSIS; STATISTICAL SIGNIFICANCE; TUBERCULOUS PERICARDITIS;

ADULT; ANALYSIS OF VARIANCE; ANTI-INFECTIVE AGENTS; ANTI-INFLAMMATORY AGENTS; CATHETERS, INDWELLING; CD4 LYMPHOCYTE COUNT; DRAINAGE; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PERICARDIAL EFFUSION; PERICARDIECTOMY; PERICARDIOCENTESIS; PERICARDITIS, TUBERCULOUS; PREDNISONE; SOUTH AFRICA; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 34247500828     PISSN: 10159657     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Strang JI. Tuberculous pericarditis in Transkei. Clin Cardiol 1984; 7: 667-670.
2. Strang JI, Nunn AJ, Johnson DA, Casbard A, Gibson DG, Girling DJ. Management of tuberculous constrictive pericarditis and tuberculous pericardial effusion in Transkei: results at 10 years follow-up. Q J Med 2004; 97: 525-535.
3. Harvey AM, Whitehill MR. Tuberculous pericarditis. Medicine 1937; 16: 45-94.
4. Rooney JJ, Crocco JA, Lyons HA. Tuberculous pericarditis. Ann Intern Med 1970; 72: 73-78.
5. Desai HN. Tuberculous pericarditis: a review of 100 cases. S Afr Med J 1979; 55: 877-880.
6. Bhan GL. Tuberculous pericarditis. J Infect 1980; 2: 360-364.
7. Strang JI, Kakaza HH, Gibson DG, Allen BW, Mitchison DA, Evans DJ, et al. Controlled clinical trial of complete open surgical drainage and of prednisolone in treatment of tuberculous pericardial effusion in Transkei. Lancet 1988; ii: 759-764.
8. Alzeer AH, Fitxgerald JM. Corticosteroids and tuberculosis: risks and use as adjuvant therapy. Tubercle Lung Dis 1993; 74: 6-11.
9. Senderovitz T, Viskum K. Corticosteroids and tuberculosis. Respir Med 1994; 88: 561-565.
10. Hakim JG, Ternouth I, Mushangi E, Siziya S, Robertson V, Malin A. Double blind randomised placebo controlled trial of adjunctive prednisolone in the treatment of effusive tuberculous pericarditis in HIV seropositive patients. Heart 2000; 84: 183-188.
11. Mayosi BM, Volmink JA, Commerford PJ. Interventions for treating tuberculous pericarditis. Cochrane Database Syst Rev 2002; 4: CD 000526.
12. Maisch B, Seferovíc PM, Ristíc AD, Erbel R, Rienmúller R, Adler Y, et al, task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology. Guidelines on the diagnosis and management of pericardial diseases executive summary; the task force on the diagnosis and management of pericardial diseases of the European Society of Cardiology. Eur Heart J 2004; 25: 587-610.
13. Tsang TS, Freeman WK, Barnes ME, Reeder GS, Packer DL, Seward JB. Rescue echocardiographically guided pericardiocentesis for cardiac perforation complicating catheter-based procedures. The Mayo Clinic experience. J Am Coll Cardiol 1998; 32: 1345-1350.
14. Tsang TS, Barnes ME, Hayes SN, Freeman WK, Dearani JA, Osborn-Butler SL, et al. Clinical and echocardiographic characteristics of significant pericardial effusions following cardiothoracic surgery and outcomes of echo-guided pericardiocentesis for management: Mayo Clinic experience, 1979-1998. Chest 1999; 116: 322-331.
15. Tsang TS, Barnes ME, Gersh BJ, Bailey KR, Seward JB. Outcomes of clinically significant idiopathic pericardial effusion requiring intervention. Am J Cardiol 2002; 91: 704-707.
16. Tsang TS, Enriquez-Sarano M, Freeman WK, Barnes ME, Sinak LJ, Gersh BJ, et al. Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: clinical profile, practice patterns, and outcomes spanning 21 years. Mayo Clin Proc 2002; 77: 429-436.
17. Seferovíc PM, Ristíc AD, Maksimovíc R, Tatic V, Ostojic M, Kanjuh V. Diagnostic value of pericardial biopsy: improvement with extensive sampling enabled by pericardioscopy. Circulation 2003; 107: 978-983.
18. Louw VJ, Reuter H, Smedema JP, Smedema JP, Katjitae I, Burgess LJ, et al. Clinical experience with echocardiographically guided pericardiocenthesis and extended drainage in a population with a high prevalence of HIV infection. Nether Heart J 2002; 10: 399-406.
19. Department of Health. The South African Tuberculosis Control Programme Practical Guidelines, 1996. Department of Health, Pretoria.
20. Guberman BA, Fowler NO, Engel PJ, Gueron M, Allen JM. Cardiac tamponade in medical patients. Circulation 1981; 64: 633-640.
21. Strang JIG, Kakaza HH, Gibson DG, Girling DJ, Nunn AJ, Fox W. Controlled trial of prednisolone as adjuvant in treatment of tuberculous constrictive pericarditis in Transkei. Lancet 1987; ii: 1418-1422.
22. Lorell BH. Pericardial diseases. In: Braunwald E, ed. Heart Disease: A Textbook of Cardiovascular Medicine. 5th edn. Philadelphia: WB Saunders; 1997: 1478-1534.
23. Reuter H, Burgess LJ, Schneider J, van Vuuren W, Doubell AF. The role of histopathology in establishing the diagnosis of tuberculous pericardial effusions in the presence of HIV. Histopathology 2006; 48: 295-302.
24. Burgess LJ, Reuter H, Carstens ME, Taljaard F, Doubell AF. The use of Adenosine deaminase and interferon- as diagnostic tools for tuberculous pericarditis. Chest 2002; 122: 900-905.
25. Reuter H, Burgess LJ, Carstens ME, Doubell AF. Adenosine deaminase activity - more than a diagnostic tool in tuberculous pericarditis. Cardiovasc J South Afr 2005; 16: 143-147.
26. Callahan JA, Seward JB, Tajik AJ. Cardiac tamponade: pericardiocentesis directed by two-dimensional echocardiography. Mayo Clin Proc 1985; 60: 344-347.
27. Kopecky SL, Callahan JA, Tajik AJ, Seward JB. Percutaneous pericardial catheter drainage: report of 42 consecutive cases. Am J Cardiol 1986; 58: 633-635.
28. Piehler JM, Pluth JR, Schaff HV, Danielson GK, Orszulak TA, Puga FJ. Surgical management of effusive pericardial disease: influence of extent of pericardial resection on clinical course. J Thorac Cardiovasc Surg 1985; 90: 506-516.
29. Drummond JB, Seward JB, Tsang TSM, Hayes SN, Miller FA (Jr). Outpatient two-dimensional echocardiography-guided pericardiocentesis. J Am Soc Echocardiogr 1998; 11: 433-435.
30. Haley JH, Tajik AJ, Danielson GK, Schaff HV, Mulvagh SL, Oh JK. Transient constrictive pericarditis: causes and natural history. J Am Coll Cardiol 2004; 43: 271-275.
31. Gooi HC, Smith JM. Tuberculous pericarditis in Birmingham. Thorax 1978; 33: 94-96.
32. Munt PW. Miliary tuberculosis in the chemotherapy era with a clinical review in 69 American adults. Medicine 1971; 51: 139-155.
33. Vijayan VK. Disseminated tuberculosis. J Ind Med Assoc 2000; 98: 107-109.
34. Narain JP, Raviglione M, Kochi A. HIV-associated tuberculosis in developing countries: epidemiology and strategies for prevention. Tubercle Lung Dis 1992; 73: 311-321.
35. Barnes PF, Le HQ, Davidson PT. Tuberculosis in patients with HIV infection. Med Clin NAm 1993; 77: 1369-1390.
36. Chaison RE, Schecter GF, Theuer CP, Rutherford GW, Echenberg DF, Hopewell PC. Tuberculosis in patients with acquired immunodeficiency syndrome. Am Rev Resp Dis 1987; 136: 570-574.
37. Grieco MH, Chmel H. Acute disseminated tuberculosis as a diagnostic problem: a clinical study based on twenty-eight cases. Am Rev Resp Dis 1974; 109: 554-560.
38. Sahn SA, Neff TA. Miliary tuberculosis. Am J Med 1974; 56: 495-505.
39. Prout S, Benatar SR. Disseminated tuberculosis: a study of 62 cases. S Afr Med J 1980; 58: 835-842.
40. Mellors JW, Munoz A, Giorgi JV, Margolick JB, Tassoni CJ, Gupta P, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997; 126: 946-954.
41. Palella FJ (Jr), Delaney KM, Moorman KC, Loveless MO, Fuhrer J, Satten GA, et al. Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. N Engl J Med 1998; 382: 853-860.
42. Mocroft A, Vella S, Benfield TL, Chiesi A, Miller V, Gargalianos P, et al. Changing patterns of mortality across Europe in patients infected with HIV-1. Lancet 1998; 352: 1725-1730.
43. Burman WJ, Jones BE. Treatment of HIV-related tuberculosis in the era of effective antiretroviral therapy. Am J Respir Crit Care Med 201; 164: 7-12.
44. Badri M, Wilsen D, Wood R. Effect of highly active antiretroviral therapy on incidence of tuberculosis in South Africa: a cohort study. Lancet 2002; 359: 2059-2064.
45. Dheda K, Lampe F, Johnson MA, Lipman MC. Outcome of HIV-associated tuberculosis in the era of highly active antiretroviral therapy. J Infect Dis 2004; 190: 1670-1676.
46. Narita M, Ashkin D, Hollender ES, Pitchenik AE. Paradoxical worsening of tuberculosis following antiretroviral therapy in patients with AIDS. Am J Resp Crit Care Med 1998; 158: 157-161.
47. Wendel KA, Alwood KS, Gachuhi, Chaisson RE, Sterling TR. Paradoxical worsening of tuberculosis in HIV-infected persons. Chest 2001; 120: 193-197.
48. Churchyard GJ, Fielding K, Charalambous S, Day JH, Corbett EL, Hayes RJ, et al. Efficacy of secondary isoniazid preventive therapy among HIV-infected Southern Africans: time to change policy? AIDS 2003; 12: 2063-2070.